account_id none on file
legal_name Acrivon Therapeutics, Inc.
ticker ACRV
cik 1781174
domain acrivon.com
linkedin_company_url none on file
entry_point_account_id none on file
name Acrivon Therapeutics Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 4 executives 0 family 0
why_nownone on file
callsnone on file
filings
• costs of outside consultants, including their fees, stock-based compensation, and related travel expenses; • expenses to acquire technologies to be used in research and development; • upfront and maintenance fees incurred under license, acquisition, and other third-party agreements; • costs related to regulatory activities, including filing fees paid to regulatory agencies and compliance with regulatory requi
filing / Aug 12, 2026 / receipt
In December 2020, the Company entered into an operating lease agreement for laboratory and office space located at 480 Arsenal Way, Watertown, Massachusetts (the “Arsenal Way Lease”).
filing / Aug 12, 2026 / receipt
• costs of outside consultants, including their fees, stock-based compensation, and related travel expenses; • expenses to acquire technologies to be used in research and development; • upfront and maintenance fees incurred under license, acquisition, and other third-party agreements; 21 • costs related to regulatory activities, including filing fees paid to regulatory agencies and compliance with regulatory
filing / May 13, 2026 / receipt
In December 2020, the Company entered into an operating lease agreement for laboratory and office space located at 480 Arsenal Way, Watertown, Massachusetts (the “Arsenal Way Lease”).
filing / May 13, 2026 / receipt
executivesnone on file
familynone on file
upcoming
| 2026-11-12 | earnings call | scheduled | ir |
changesnone on file
mcp_package_hint
slug acrivon-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$